<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9341756" created="06/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9341756</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Induction of <term id="T1" lex="endothelial_cell_surface_adhesion_molecule" sem="Protein_family_or_group">endothelial cell surface adhesion molecules</term> by <term id="T2" lex="tumor_necrosis_factor" sem="Protein_family_or_group">tumor necrosis factor</term> is blocked by <term id="A1" sem="Organic_compound_other">protein <term id="T3" lex="tyrosine" sem="Amino_acid_monomer">tyrosine</term> <term id="T4" lex="phosphatase_inhibitor" sem="Organic_compound_other">phosphatase inhibitors</term></term>: role of the <term id="T5" lex="nuclear_transcription_factor_NF-kappa_B" sem="Protein_complex">nuclear <term id="T6" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> <term id="T7" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term></term>.</sentence>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="T1"/>
<cause idref="T2"/>
<clue><clueType>Induction</clueType> <linkTheme>of</linkTheme> endothelial cell surface adhesion molecules <linkCause>by</linkCause> tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="A1"/>
<clue>Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is <clueType>blocked</clueType> <linkCause>by</linkCause> protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Regulation"/>
<cause idref="T7"/>
<clue>Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: <clueType>role</clueType> <linkCause>of</linkCause> the nuclear transcription factor NF-kappa B.</clue>
<comment>NO THEME</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Recent studies from our laboratory have indicated that <term id="T8" lex="protein_tyrosine_phosphatase_(PTPase)_inhibitor" sem="Organic_compound_other"><term id="T9" lex="protein_tyrosine_phosphatase" sem="Protein_molecule">protein tyrosine phosphatase</term> <term id="A5" sem="Organic_compound_other">(<term id="T10" lex="PTPase" sem="Protein_molecule">PTPase</term>) inhibitors</term></term> can down-modulate the <term id="T12" lex="tumor_necrosis_factor" sem="Protein_family_or_group">tumor necrosis factor</term> (<term id="T13" lex="TNF" sem="Protein_family_or_group">TNF</term>)-mediated <term id="T11" sem="Other">activation</term> of the <term id="T14" lex="nuclear_transcription_factor_NF-kappa_B" sem="Protein_complex">nuclear transcription factor <term id="A2" sem="Protein_complex">NF-kappa B</term></term> in <term id="T15" lex="ML-1a" sem="Cell_cultured">ML-1a</term>, a <term id="T16" lex="monocytic_cell_line" sem="Cell_cultured">monocytic cell line</term> (Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631).</sentence>
<event CL="L2" KT="Analysis" Source="Other" id="E4" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="A5"/>
<clue><clueSource>Recent studies from our laboratory</clueSource> have <clueKT>indicated</clueKT> that protein tyrosine phosphatase (PTPase) inhibitors <clueCL>can</clueCL> <clueType>down-modulate</clueType> the tumor necrosis factor (TNF)-mediated activation of the nuclear transcription factor NF-kappa B in ML-1a, a monocytic cell line <clueSource>(Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631)</clueSource>.</clue>
</event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="T13"/>
<clue>Recent studies from our laboratory have indicated that protein tyrosine phosphatase (PTPase) inhibitors can down-modulate the tumor necrosis factor (TNF)<linkCause>-mediated</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> the nuclear transcription factor NF-kappa B <clueLoc>in ML-1a, a monocytic cell line</clueLoc> (Singh and Aggarwal, J. Biol. Chem. 1995: 270: 10631).</clue>
</event>
<sentence id="S3">Since <term id="T17" lex="TNF" sem="Protein_family_or_group">TNF</term> is one of the major inducers of various <term id="T18" lex="adhesion_molecule" sem="Protein_family_or_group">adhesion molecules</term> in human endothelial cells and their expression is known to require the activation of <term id="T19" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>, we examined the effect of <term id="T20" lex="PTPase_inhibitor" sem="Organic_compound_other"><term id="T21" lex="PTPase" sem="Protein_family_or_group">PTPase</term> inhibitors</term> on the <term id="T23" lex="TNF" sem="Protein_family_or_group">TNF</term>-mediated <term id="T22" sem="Other">induction</term> of <term id="T24" lex="intracellular_adhesion_molecule_(ICAM)-1" sem="Protein_molecule">intracellular adhesion molecule <term id="A6" sem="Protein_molecule">(ICAM)-1</term></term>, <term id="T25" lex="vascular_cell_adhesion_molecule_(VCAM)-1" sem="Protein_molecule">vascular cell adhesion molecule <term id="A7" sem="Protein_molecule">(VCAM)-1</term></term> and <term id="T26" lex="endothelial_leukocyte_adhesion_molecule_(ELAM)-1" sem="Protein_molecule">endothelial leukocyte adhesion molecule <term id="A8" sem="Protein_molecule">(ELAM)-1</term></term>.</sentence>
<event KT="Fact" id="E42">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<cause idref="T17"/>
<clue>Since TNF is one of the major <clueType>inducers</clueType> <linkTheme>of</linkTheme> various adhesion molecules <clueLoc>in human endothelial cells</clueLoc> and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event KT="Other" id="E43">
<type class="Gene_expression"/>
<theme idref="T18"/>
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their <clueType>expression</clueType> is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event KT="Fact" id="E44">
<type class="Positive_regulation"/>
<theme idref="E43"/>
<cause idref="E45"/>
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is <clueKT>known</clueKT> to <clueType>require</clueType> the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event KT="Other" id="E45">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B, we examined the effect of PTPase inhibitors on the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event KT="Investigation" id="E6" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E9"/>
<cause idref="T20"/>
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> PTPase inhibitors <linkTheme>on</linkTheme> the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event KT="Investigation" id="E7" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E10"/>
<cause idref="T20"/>
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> PTPase inhibitors <linkTheme>on</linkTheme> the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="T20"/>
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> PTPase inhibitors <linkTheme>on</linkTheme> the TNF-mediated induction of intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event KT="Other" id="E9">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="T23"/>
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF<linkCause>-mediated</linkCause> <clueType>induction</clueType> <linkTheme>of</linkTheme> intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="A7"/>
<cause idref="T23"/>
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF<linkCause>-mediated</linkCause> <clueType>induction</clueType> <linkTheme>of</linkTheme> intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<cause idref="T23"/>
<clue>Since TNF is one of the major inducers of various adhesion molecules in human endothelial cells and their expression is known to require the activation of NF-kappa B, we examined the effect of PTPase inhibitors on the TNF<linkCause>-mediated</linkCause> <clueType>induction</clueType> <linkTheme>of</linkTheme> intracellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1 and endothelial leukocyte adhesion molecule (ELAM)-1.</clue>
</event>
<sentence id="S4">Like <term id="T27" lex="ML-1a" sem="Cell_cultured">ML-1a</term>, <term id="T28" lex="human_dermal_microvessel_endothelial_cell" sem="Cell_cultured">human dermal microvessel endothelial cells</term> (<term id="T29" lex="MVEC" sem="Cell_cultured">MVEC</term>) treated with <term id="T30" lex="TNF" sem="Protein_family_or_group">TNF</term> rapidly activated (within 30 min) <term id="T31" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>; this effect was completely abolished by co-treatment with <term id="T32" lex="phenylarsine_oxide" sem="Organic_compound_other">phenylarsine oxide</term> (<term id="T33" lex="PAO" sem="Organic_compound_other">PAO</term>), a specific inhibitor of <term id="T34" lex="PTPase" sem="Protein_family_or_group">PTPase</term>.</sentence>
<event KT="Method" id="E12">
<type class="Artificial_process"/>
<theme idref="T29"/>
<theme idref="T30"/>
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) <clueType>treated</clueType> <linkTheme>with</linkTheme> TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
</event>
<event Manner="High" id="E13">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="E12"/>
<clue>Like ML-1a, <clueLoc>human dermal microvessel endothelial cells (MVEC) treated with TNF</clueLoc> <clueManner>rapidly</clueManner> <clueType>activated</clueType> (<clueTime>within 30 min</clueTime>) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
</event>
<event id="E14">
<type class="Negative_regulation"/>
<theme idref="E13"/>
<cause idref="E12"/>
<cause idref="E15"/>
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) treated with TNF rapidly activated (within 30 min) NF-kappa B; <corefTheme>this effect</corefTheme> was completely <clueType>abolished</clueType> <linkCause>by</linkCause> co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
</event>
<event KT="Method" id="E15">
<type class="Artificial_process"/>
<theme idref="T29"/>
<theme idref="T33"/>
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) treated with TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by <clueType>co-treatment</clueType> <linkTheme>with</linkTheme> phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
</event>
<event KT="Fact" id="E46">
<type class="Negative_regulation"/>
<theme idref="T34"/>
<cause idref="T33"/>
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) treated with TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> PTPase.</clue>
</event>
<event KT="Method" id="E47">
<type class="Artificial_process"/>
<theme idref="T27"/>
<theme idref="T30"/>
<clue>Like ML-1a, human dermal microvessel endothelial cells (MVEC) <clueType>treated</clueType> <linkTheme>with</linkTheme> TNF rapidly activated (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
<comment>CAUTION: SEE</comment></event>
<event KT="Other" Manner="High" id="E48">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="E47"/>
<clue>Like <clueLoc>ML-1a</clueLoc>, human dermal microvessel endothelial cells (MVEC) <clueLoc>treated with TNF</clueLoc> <clueManner>rapidly</clueManner> <clueType>activated</clueType> (within 30 min) NF-kappa B; this effect was completely abolished by co-treatment with phenylarsine oxide (PAO), a specific inhibitor of PTPase.</clue>
<comment>CAUTION: SEE</comment></event>
<sentence id="S5">The induction of <term id="T35" lex="ICAM-1" sem="Protein_molecule">ICAM-1</term>, <term id="T36" lex="VCAM-1" sem="Protein_molecule">VCAM-1</term>, and <term id="T37" lex="ELAM-1" sem="Protein_molecule">ELAM-1</term> by <term id="T38" lex="TNF" sem="Protein_family_or_group">TNF</term> in <term id="T39" lex="MVEC" sem="Cell_cultured">MVEC</term> occurred within 6 h and was also completely down-regulated by <term id="T40" lex="PAO" sem="Organic_compound_other">PAO</term> in a dose-dependent manner.</sentence>
<event id="E16">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<cause idref="T38"/>
<clue>The <clueType>induction</clueType> <linkTheme>of</linkTheme> ICAM-1, VCAM-1, and ELAM-1 <linkCause>by</linkCause> TNF <clueLoc>in MVEC</clueLoc> occurred <clueTime>within 6 h</clueTime> and was also completely down-regulated by PAO in a dose-dependent manner.</clue>
</event>
<event id="E17">
<type class="Positive_regulation"/>
<theme idref="T36"/>
<cause idref="T38"/>
<clue>The <clueType>induction</clueType> <linkTheme>of</linkTheme> ICAM-1, VCAM-1, and ELAM-1 <linkCause>by</linkCause> TNF <clueLoc>in MVEC</clueLoc> occurred <clueTime>within 6 h</clueTime> and was also completely down-regulated by PAO in a dose-dependent manner.</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<cause idref="T38"/>
<clue>The <clueType>induction</clueType> <linkTheme>of</linkTheme> ICAM-1, VCAM-1, and ELAM-1 <linkCause>by</linkCause> TNF <clueLoc>in MVEC</clueLoc> occurred <clueTime>within 6 h</clueTime> and was also completely down-regulated by PAO in a dose-dependent manner.</clue>
</event>
<event Manner="High" id="E19">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<cause idref="T40"/>
<clue>The induction of ICAM-1, VCAM-1, and ELAM-1 by TNF in MVEC occurred within 6 h and was also <clueManner>completely</clueManner> <clueType>down-regulated</clueType> <linkCause>by</linkCause> PAO in a dose-dependent manner.</clue>
</event>
<event Manner="High" id="E20">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T40"/>
<clue>The induction of ICAM-1, VCAM-1, and ELAM-1 by TNF in MVEC occurred within 6 h and was also <clueManner>completely</clueManner> <clueType>down-regulated</clueType> <linkCause>by</linkCause> PAO in a dose-dependent manner.</clue>
</event>
<event Manner="High" id="E21">
<type class="Negative_regulation"/>
<theme idref="E18"/>
<cause idref="T40"/>
<clue>The induction of ICAM-1, VCAM-1, and ELAM-1 by TNF in MVEC occurred within 6 h and was also <clueManner>completely</clueManner> <clueType>down-regulated</clueType> <linkCause>by</linkCause> PAO in a dose-dependent manner.</clue>
</event>
<sentence id="S6"><term id="T41" lex="PAO" sem="Organic_compound_other">PAO</term> was found to be effective even when added 3 h after <term id="T42" lex="TNF" sem="Protein_family_or_group">TNF</term>, suggesting a rapid mode of action of this inhibitor.</sentence>
<event id="E22">
<type class="Negative_regulation"/>
<cause idref="E24"/>
<cause idref="E23"/>
<clue>PAO was <clueKT>found</clueKT> to be <clueType>effective</clueType> even <linkCause>when</linkCause> added 3 h <linkCause>after</linkCause> TNF, suggesting a rapid mode of action of this inhibitor.</clue>
<comment>CAUTION: be effective=down-regulation; NO THEME</comment></event>
<event KT="Method" id="E23">
<type class="Artificial_process"/>
<theme idref="T41"/>
<clue>PAO was found to be effective even when <clueType>added</clueType> <clueTime>3 h after TNF</clueTime>, suggesting a rapid mode of action of this inhibitor.</clue>
</event>
<event KT="Method" id="E24">
<type class="Artificial_process"/>
<theme idref="T42"/>
<clue>PAO was found to be effective even when <clueType>added</clueType> 3 h after TNF, suggesting a rapid mode of action of this inhibitor.</clue>
</event>
<sentence id="S7">Besides <term id="T43" lex="PAO" sem="Organic_compound_other">PAO</term>, other inhibitors of <term id="T44" lex="PTPase" sem="Protein_family_or_group">PTPase</term>, including <term id="T45" lex="pervanadate" sem="Organic_compound_other">pervanadate</term> and <term id="A3" sem="Organic_compound_other">diamide</term>, also blocked <term id="T47" lex="TNF" sem="Protein_family_or_group">TNF</term>-dependent <cons id="C1" lex="(AND NF-kappa_B_activation NF-kappa_b_induction)" sem="(AND Other Other)"><frag id="F1">NF-kappa B</frag> <frag id="F2">activation</frag> and <frag id="F3">induction</frag></cons> of all the three <term id="T49" lex="adhesion_protein" sem="Protein_family_or_group">adhesion proteins</term>.</sentence>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="T45"/>
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="T45"/>
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T45"/>
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E28">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T45"/>
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event KT="Other" id="E29">
<type class="Positive_regulation"/>
<theme idref="F1"/>
<cause idref="T47"/>
<clue>Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF<linkCause>-dependent</linkCause> NF-kappa B <clueType>activation</clueType> and induction of all the three adhesion proteins.</clue>
</event>
<event KT="Other" id="E30">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<clue>Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF-dependent NF-kappa B activation and <clueType>induction</clueType> <linkTheme>of</linkTheme> <corefTheme>all the three adhesion proteins</corefTheme>.</clue>
</event>
<event KT="Other" id="E31">
<type class="Positive_regulation"/>
<theme idref="T36"/>
<clue>Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF-dependent NF-kappa B activation and <clueType>induction</clueType> <linkTheme>of</linkTheme> <corefTheme>all the three adhesion proteins</corefTheme>.</clue>
</event>
<event KT="Other" id="E32">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<clue>Besides PAO, other inhibitors of PTPase, including pervanadate and diamide, also blocked TNF-dependent NF-kappa B activation and <clueType>induction</clueType> <linkTheme>of</linkTheme> <corefTheme>all the three adhesion proteins</corefTheme>.</clue>
</event>
<event id="E33">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="A3"/>
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="E30"/>
<cause idref="A3"/>
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="A3"/>
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<event id="E36">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="A3"/>
<clue>Besides PAO, <corefCause>other inhibitors of PTPase</corefCause>, including pervanadate and diamide, also <clueType>blocked</clueType> TNF-dependent NF-kappa B activation and induction of all the three adhesion proteins.</clue>
</event>
<sentence id="S8">Consistent with these results, the attachment of <term id="A4" sem="Cell_natural">monocytes</term> to <term id="T50" lex="MVEC" sem="Cell_cultured">MVEC</term> was also blocked by the <term id="T51" lex="PTPase_inhibitor" sem="Organic_compound_other"><term id="T52" lex="PTPase" sem="Protein_family_or_group">PTPase</term> inhibitors</term>.</sentence>
<event KT="Other" id="E37">
<type class="Cell_adhesion"/>
<theme idref="A4"/>
<theme idref="T50"/>
<clue>Consistent with these results, the <clueType>attachment</clueType> <linkTheme>of</linkTheme> monocytes <linkTheme>to</linkTheme> MVEC was also blocked by the PTPase inhibitors.</clue>
</event>
<event id="E38">
<type class="Negative_regulation"/>
<theme idref="E37"/>
<cause idref="T51"/>
<clue>Consistent with these results, the attachment of monocytes to MVEC <clueType>was</clueType> also <clueType>blocked</clueType> <linkCause>by</linkCause> the PTPase inhibitors.</clue>
</event>
<sentence id="S9">Thus, overall, our results demonstrate that a <term id="T53" lex="PTPase" sem="Protein_family_or_group">PTPase</term> is involved either directly or indirectly in the pathway leading to the induction of <term id="T54" lex="endothelial_cell_adhesion_molecule" sem="Protein_family_or_group">endothelial cell <term id="T55" lex="adhesion_molecule" sem="Protein_family_or_group">adhesion molecules</term></term> by <term id="T56" lex="TNF" sem="Protein_family_or_group">TNF</term>.</sentence>
<event KT="Analysis" id="E39">
<type class="Positive_regulation"/>
<theme idref="E40"/>
<cause idref="T53"/>
<clue>Thus, overall, our results <clueKT>demonstrate</clueKT> that a PTPase is <clueType>involved</clueType> either directly or indirectly <clueType>in the pathway leading</clueType> <linkTheme>to</linkTheme> the induction of endothelial cell adhesion molecules by TNF.</clue>
</event>
<event KT="Other" id="E40">
<type class="Positive_regulation"/>
<theme idref="T54"/>
<cause idref="T56"/>
<clue>Thus, overall, our results demonstrate that a PTPase is involved either directly or indirectly in the pathway leading to the <clueType>induction</clueType> <linkTheme>of</linkTheme> endothelial cell adhesion molecules <linkCause>by</linkCause> TNF.</clue>
</event>
<sentence id="S10">Because of their role in <term id="T57" lex="cell_adhesion" sem="Other">cell adhesion</term>, <term id="T58" lex="PTPase" sem="Protein_family_or_group">PTPase</term> may provide a novel target of drug development for treatment of <term id="T59" lex="inflammation" sem="Other">inflammation</term>, <term id="T60" lex="atherogenesis" sem="Other">atherogenesis</term>, and <term id="T61" lex="tumor_metastasis" sem="Other">tumor metastasis</term>.</sentence>
<event KT="Other" id="E41">
<type class="Regulation"/>
<theme idref="T57"/>
<cause idref="T58"/>
<clue>Because of their <clueType>role</clueType> <linkTheme>in</linkTheme> cell adhesion, PTPase may provide a novel target of drug development for treatment of inflammation, atherogenesis, and tumor metastasis.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
